ストックスクリーナーアプリを入手
548.13
1.04%
5.4673
前日終値:
$542.66
開ける：
$545.58
24時間の取引高:
138.40K
Relative Volume:
0.28
時価総額：
$23.27B
収益：
$3.17B
当期純損益:
$1.29B
株価収益率:
20.23
EPS:
27.0947
ネットキャッシュフロー:
$1.01B
1週間 パフォーマンス:
+1.86%
1か月 パフォーマンス:
-1.52%
6か月 パフォーマンス:
+9.03%
1年 パフォーマンス:
+92.89%
1日の値動き範囲:
$539.14
$549.38
1週間の範囲:
$535.44
$555.32
52週間の値動き範囲:
$272.12
$609.35
United Therapeutics Corp Stock (UTHR) Company Profile
名前
United Therapeutics Corp
セクター
電話
(301) 608-9292
住所
1000 SPRING ST, SILVER SPRING, MD
Compare UTHR vs TAK, HLN, TEVA, ZTS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
548.24 | 23.03B | 3.17B | 1.29B | 1.01B | 27.09 |
TAK
Takeda Pharmaceutical Co Adr
|
15.88 | 50.27B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.315 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.17 | 38.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
73.97 | 31.90B | 9.51B | 2.64B | 2.14B | 6.0361 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 開始されました | Raymond James | Outperform |
| 2025-10-20 | 開始されました | Wells Fargo | Underweight |
| 2025-09-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-06-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | アップグレード | Goldman | Sell → Neutral |
| 2024-02-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2022-12-06 | 開始されました | UBS | Buy |
| 2022-12-05 | 開始されました | Goldman | Sell |
| 2022-10-11 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-20 | 繰り返されました | BofA Securities | Underperform |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-02-11 | 開始されました | BTIG Research | Neutral |
| 2021-07-14 | アップグレード | Argus | Hold → Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-02-01 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-06-25 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-03-10 | アップグレード | Jefferies | Hold → Buy |
| 2020-02-27 | アップグレード | Cowen | Market Perform → Outperform |
| 2020-01-31 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 開始されました | BofA/Merrill | Underperform |
| 2019-08-01 | アップグレード | Jefferies | Underperform → Hold |
| 2019-08-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | アップグレード | UBS | Sell → Neutral |
| 2019-05-09 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | アップグレード | Standpoint Research | Hold → Buy |
| 2018-08-08 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 繰り返されました | Barclays | Underweight |
| 2018-01-18 | 再開されました | Credit Suisse | Underperform |
| 2017-12-27 | 繰り返されました | Wedbush | Outperform |
| 2017-04-27 | 繰り返されました | Wedbush | Outperform |
| 2017-03-30 | 開始されました | UBS | Sell |
| 2017-03-16 | 開始されました | Credit Suisse | Underperform |
すべてを表示
United Therapeutics Corp (UTHR) 最新ニュース
United Therapeutics (UTHR) Secures FDA Approval for LungFX - GuruFocus
United Therapeutics (UTHR) Receives FDA Approval for LungFX Devi - GuruFocus
FDA approves United Therapeutics’ LungFX lung perfusion device - Investing.com
FDA approves United Therapeutics’ LungFX lung perfusion device By Investing.com - Investing.com India
FDA approves United Therapeutics' LungFX to assess donor lungs - Stock Titan
United Therapeutics CEO Martine Rothblatt sells $5.2m in shares By Investing.com - Investing.com South Africa
United Therapeutics CEO Martine Rothblatt sells $5.2m in shares - Investing.com
Form 4 United Therapeutics Corporation For: 26 June By Investing.com - Investing.com Canada
United Therapeutics Corp Annual Shareholders Meeting Transcript - GuruFocus
Martine A. Rothblatt sells $5.2m United Therapeutics shares - Investing.com UK
Martine A. Rothblatt sells $5.2m United Therapeutics shares By Investing.com - Investing.com Australia
Form 4 United Therapeutics Corporation For: 25 June By Investing.com - Investing.com Canada
United Therapeutics chairperson & CEO sells $5.17m in stock - Investing.com UK
United Therapeutics chairperson & CEO sells $5.17m in stock By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.1m in UTHR shares By Investing.com - Investing.com South Africa
Form 4 United Therapeutics Corporation For: 24 June By Investing.com - Investing.com Australia
United Therapeutics CEO Rothblatt sells $5.1m in UTHR shares - Investing.com
United Therapeutics - Forbes
Martine Rothblatt, United Therapeutics CEO, sells $5.1m in stock By Investing.com - Investing.com Australia
Martine Rothblatt, United Therapeutics CEO, sells $5.1m in stock - Investing.com UK
Form 4 United Therapeutics Corporation For: 22 June By Investing.com - Investing.com Australia
United Therapeutics Corp (UTHR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks - StockStory
United Therapeutics EVP Mahon sells $4.5m in company stock - Investing.com UK
United Therapeutics EVP Mahon sells $4.5m in company stock By Investing.com - Investing.com South Africa
United Therapeutics StockThursday technical picture and trading levels - AD HOC NEWS
United Therapeutics Corp (UTHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
United Therapeutics (UTHR) EVP & General Counsel exercises options, sells 8,300 shares in 10b5-1 trades - Stock Titan
United Therapeutics CEO Rothblatt sells $5.2m in shares - Investing.com
United Therapeutics CEO Rothblatt sells $5.2m in shares By Investing.com - Investing.com Australia
United Therapeutics' Liver Assist Product Earns FDA Regenerative Medicine Advanced Therapy Designation - Medical Product Outsourcing
United Therapeutics CFO Edgemond sells $5.49m in common stock By Investing.com - Investing.com India
United Therapeutics CFO Edgemond sells $5.49m in common stock - Investing.com
United Therapeutics Corp (UTHR) 財務データ
収益
当期純利益
現金流量
EPS
1.01%
2.77%
大文字化:
|
ボリューム (24 時間):